Dr. Dincman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
169 Ashley Ave
Room 202 Main Hospital, Msc333
Charleston, SC 29425Phone+1 843-792-4074
Education & Training
Medical University of South CarolinaResidency, Internal Medicine, 2013 - 2016
University of Louisville School of MedicineClass of 2013- Medical University of South CarolinaFellowship, Hematology and Medical Oncology
Certifications & Licensure
SC State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Start of enrollment: 2018 Jun 19
Roles: Contact
Publications & Presentations
PubMed
- The RNA-binding protein PCBP1 modulates transcription by recruiting the G-quadruplex-specific helicase DHX9.Joseph A Q Karam, Cécile Fréreux, Bidyut K Mohanty, Annamarie C Dalton, Toros A Dincman
The Journal of Biological Chemistry. 2024-11-01 - RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma.Mrinmoyee Majumder, Harinarayanan Janakiraman, Paramita Chakraborty, Anitha Vijayakumar, Sari Mayhue
Oral Oncology Reports. 2024-06-01 - Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer.Toros A Dincman, Joseph A Q Karam, Antonio Giordano, Hong Li, Leylah M Drusbosky
Frontiers in Oncology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
